{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:05:58Z","timestamp":1781712358519,"version":"3.54.5"},"reference-count":20,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"funding associated"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2121109","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T20:31:42Z","timestamp":1664310702000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report"],"prefix":"10.1080","volume":"18","author":[{"given":"Wei-Ling","family":"Li","sequence":"first","affiliation":[{"name":"Department of Oncology, Changzhi People\u2019s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China"},{"name":"Graduate School, Changzhi Medical College, Changzhi, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changzhi People\u2019s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China"},{"name":"Graduate School, Changzhi Medical College, Changzhi, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changzhi People\u2019s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yi","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changzhi People\u2019s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Changzhi People\u2019s Hospital Affiliated to Changzhi Medical College, Changzhi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changzhi People\u2019s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-014-0402-y"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61121-X"},{"key":"e_1_3_4_5_1","unstructured":"FDA Approves Merck\u2019s KEYTRUDA\u00ae (pembrolizumab). Combined with trastuzumab and chemotherapy as first-line treatment in locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma."},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7243"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-019-0349-9"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30007-4"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.043562"},{"key":"e_1_3_4_10_1","unstructured":"FDA Approves Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) for previously treated patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer whose tumors express PD-L1 (CPS greater than or equal to 1). 2017."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1728250"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30169-8"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.3081"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0737"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30326-0"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-83"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13731"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093078"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1199311"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0013"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.3370"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2121109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:30:44Z","timestamp":1737048644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2121109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2121109"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2121109","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2121109"}}